Autonomic Dysfunction Related to Postacute SARS-CoV-2 Syndrome - 06/07/23

Doi : 10.1016/j.pmr.2023.04.003

Justin Haloot, DO, MS ^a, Ratna Bhavaraju-Sanka, MD ^b,^⁎ , Jayasree Pillarisetti, MD, Msc ^c, Monica Verduzco-Gutierrez, MD ^d
^a Department of Internal Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
^b Department of Neurology, UT Health San Antonio, Joe R. & Theresa Lozano Long School of Medicine, 7703 Floyd Curl Drive, Mail Code 7883, San Antonio, TX 78229, USA
^c Janey & Dolph Briscoe Division of Cardiology, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
^d Department of Rehabilitation Medicine, Joe R. & Teresa Lozano Long School of Medicine, UT Health at San Antonio Texas, 7703 Floyd Curl Drive, Room 628E, San Antonio, TX 78229, USA

^∗Corresponding author.

connettersi o creare un account

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Riassunto

Persistence of symptoms beyond the initial acute phase of coronavirus disease-2019 (COVID-19) is termed postacute SARS-CoV-2 (PASC) and includes neurologic, autonomic, pulmonary, cardiac, psychiatric, gastrointestinal, and functional impairment. PASC autonomic dysfunction can present with dizziness, tachycardia, sweating, headache, syncope, labile blood pressure, exercise intolerance, and “brain fog.” A multidisciplinary team can help manage this complex syndrome with nonpharmacologic and pharmacologic interventions.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : PASC, Autonomic dysfunction, COVID-19, Brain fog, Tilt table test